A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma-Reference-Cited by-同舟云学术

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma

Published:2017-02 Issue:1 Volume:15 Page:77-85
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Apolo Andrea B.,Karzai Fatima H.,Trepel Jane B.,Alarcon Sylvia,Lee Sunmin,Lee Min-Jung,Tomita Yusuke,Cao Liang,Yu Yunkai,Merino Maria J.,Madan Ravi A.,Parnes Howard L.,Steinberg Seth M.,Rodriguez Beatriz Walter,Seon Ben K.,Gulley James L.,Arlen Philip M.,Dawson Nancy A.,Figg William D.,Dahut William L.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference59 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000

3. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986;De Santis;J Clin Oncol,2012

4. Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma;McCaffrey;J Clin Oncol,1997

5. Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer;Vaughn;J Clin Oncol,2002

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial;Nature Communications;2024-03-30

2. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis;Clinical Cancer Research;2023-07-11

3. Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review;International Journal of Molecular Sciences;2023-06-27

4. A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer;Breast Cancer Research and Treatment;2023-02-03

5. A Phase I/II Study of Preoperative Letrozole, Everolimus, and Carotuximab in Stage 2 and 3 Hormone Receptor-positive and Her2-negative Breast Cancer.;2022-10-26